TechNavio's analysts forecast the Global Nanotechnology Drug Delivery market to grow at a CAGR of 73.97 percent over the period 2012-2016. One of the key factors contributing to this market growth is the low R&D cost. The Global Nanotechnology Drug Delivery market has also been witnessing an increase in customer support services. However, the increasing safety concerns could pose a challenge to the growth of this market.... Research Beam Model: Research Beam Product ID: 16403 2000 USD New
Global Nanotechnology Drug Delivery Market 2012-2016
 

Global Nanotechnology Drug Delivery Market 2012-2016

Global Nanotechnology Drug Delivery Market 2012-2016

Category : Healthcare

request-discount
TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

TechNavio's analysts forecast the Global Nanotechnology Drug Delivery market to grow at a CAGR of 73.97 percent over the period 2012-2016. One of the key factors contributing to this market growth is the low R&D cost. The Global Nanotechnology Drug Delivery market has also been witnessing an increase in customer support services. However, the increasing safety concerns could pose a challenge to the growth of this market. 

TechNavio's report, Global Nanotechnology Drug Delivery Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it covers the Global Nanotechnology Drug Delivery market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this space are IOTA NanoSolutions Ltd., Lena Nanoceutics Ltd., GlaxoSmithKline plc, Celgene Corp., and SkyePharma plc.

The other vendors mentioned in the report are Merck & Co. Inc., Pfizer Inc., AlphaRx Inc., Amgen Inc., Angiotech Pharmaceuticals Inc., Biophan Technologies Inc., Calando Pharmaceuticals Inc., Cephalon Inc., Cerulean Pharma Inc., Copernicus Therapeutics Inc., CritiTech Inc., CytImmune Sciences Inc., Elan Corp. plc, Debiotech SA, F. Hoffmann-La Roche Ltd., Nano Interface Technology Inc., Spherics Inc., Spectrum Pharmaceuticals Inc., SoluBest Ltd., Sigma-Tau Pharmaceuticals Inc., PharmaNova Inc., Particle Sciences Inc., Novavax Inc., Nanotherapeutics Inc., NanoSight Ltd., NanoCarrier Co. Ltd., NanoBioMagnetics Inc., Nano Interface Technology Inc., Merck Sharp & Dohme Corp., Kuecept Ltd., and Izon Science Ltd.

Key questions answered in this report:
What will the market size be in 2016 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of each of these key vendors?

01. Executive Summary

02. List of Abbreviations

03. Introduction

04. Market Coverag
e

Market Overview

Key Offerings

05. Market Landscape

05.1 Market Size and Forecast

05.2 Market Segmentation of the Global Nanotechnology Drug Delivery Market

Market Segmentation by Technology

05.3 Five Forces Analysis

06. Geographical Segmentation

07. Vendor Landscape

08. Buying Criteria

09. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends 

14. Key Vendor Analysis


14.1 IOTA NanoSolutions Ltd.

Business Overview

SWOT Analysis

14.2 Celgene Corp.

Business Overview

Key Information

SWOT Analysis

14.3 GlaxoSmithKline plc

Business Overview

SWOT Analysis

14.4 Lena Nanoceutics Ltd.

Business Overview

Key Information

SWOT Analysis

14.5 SkyePharma plc 

Business Overview

SWOT Analysis

15. Other Reports in this Series



List of Exhibits

Exhibit 1: Global Nanotechnology Drug Delivery Market 2012-2016(US$ billion)

Exhibit 2: Global Nanotechnology Drug Delivery Market Segmentation by Technology

Exhibit 3: Global Nanotechnology Drug Delivery Market Segmentation 2012 (percentage)

Exhibit 4: Global Nanocarrier Market Share by Technology 2012 (percentage)

Exhibit 5: Global Nanotechnology Drug Delivery Market by Geographical Segmentation 2012



 



Enquiry Before Buy